Results 121 to 130 of about 136,561 (344)

Tsc1-Tp53 loss induces mesothelioma in mice, and evidence for this mechanism in human mesothelioma [PDF]

open access: yes, 2015
Mesothelioma is diagnosed in approximately 2,500 patients in the United States every year, most often arising in the pleural space, but also occurring as primary peritoneal mesothelioma.
Bueno, Raphael   +6 more
core   +1 more source

Mesothelioma [PDF]

open access: yesJournal of Thoracic Oncology, 2012
Felley-Bosco, Emanuela, Opitz, Isabelle
openaire   +3 more sources

Intercellular Communication in Malignant Pleural Mesothelioma: Properties of Tunneling Nanotubes

open access: yesFrontiers in Physiology, 2014
Malignant pleural mesothelioma is a particularly aggressive and locally invasive malignancy with a poor prognosis despite advances in understanding of cancer cell biology and development of new therapies.
Justin William Ady   +10 more
doaj   +1 more source

Concomitant Nephrotic Syndrome and Cryoglobulinemia in a Case of Malignant Mesothelioma

open access: yesCase Reports in Nephrology, 2022
Malignant pleural mesothelioma is rarely associated with nephrotic syndrome. Cryoglobulinemia is found in various pathological statuses, such as hepatitis C virus infection but rarely in malignant neoplasms.
Kei Nagai   +3 more
doaj   +1 more source

Malignant Pleural Effusion: Palliative Managements and Indication for Pleurodesis Based on Survival Scores

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Neoplastic pleural effusion is one in which malignant neoplastic cells are detected in the pleural fluid or in the parietal pleura. When secondary, it confirms disseminated neoplastic disease and suggests a reduced life expectancy and low quality of life.
Erlon de Avila Carvalho   +9 more
wiley   +1 more source

The YAP1 Signaling Inhibitors, Verteporfin and CA3, Suppress the Mesothelioma Cancer Stem Cell Phenotype

open access: yesMolecular Cancer Research, 2019
Mesothelioma is an aggressive cancer that has a poor prognosis. Tumors develop in the mesothelial lining of the pleural and peritoneal cavities in response to asbestos exposure. Surgical debulking followed by chemotherapy is initially effective, but this
Sivaveera Kandasamy   +6 more
semanticscholar   +1 more source

Evaluating Respiratory Complications Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Subphrenic Peritonectomy Versus Full Thickness Diaphragm Resection

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Patients with diaphragm tumor deposits undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) require subphrenic peritonectomy (SPP) or full‐thickness diaphragm resection (FTR) to achieve complete cytoreduction.
Claire Liu   +4 more
wiley   +1 more source

Versican modulates tumor-associated macrophage properties to stimulate mesothelioma growth

open access: yesOncoImmunology, 2019
Versican promotes experimental tumor growth through cell- and non cell-autonomous mechanisms. Its role in mesothelioma progression has not been investigated so far.
Apostolos G. Pappas   +8 more
doaj   +1 more source

The use of ROTEM in Detection of Coagulopathy and Altered Hemostasis in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background Patients undergoing Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) are at risk of coagulopathy. This study aims to evaluate the potential role of rotational thromboelastometry (ROTEM) in detecting alterations in coagulation during and after CRS/HIPEC.
Abdullah Mashat   +7 more
wiley   +1 more source

Comments on the Causation of Malignant Mesothelioma: Rebutting the False Concept That Recent Exposures to Asbestos Do Not Contribute to Causation of Mesothelioma

open access: yesAnnals of Global Health, 2016
Background: European asbestos manufacturers and their expert witnesses have advanced the claim that recent exposures to asbestos are not of significance in the causation of malignant mesothelioma.
Phillip J. Landrigan   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy